• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢疾病与病态肥胖的外科治疗。

The surgical treatment of metabolic disease and morbid obesity.

机构信息

Sentara Metabolic and Weight Loss Surgery Center, 600 Gresham Drive, Norfolk, VA 23507, USA.

出版信息

Gastroenterol Clin North Am. 2010 Mar;39(1):125-33. doi: 10.1016/j.gtc.2009.12.010.

DOI:10.1016/j.gtc.2009.12.010
PMID:20202585
Abstract

The disease of obesity has continued to increase in the United States. Obesity is defined as a body mass index (BMI) greater than 30 kg/m(2). In 1991, the National Institute of Health Consensus Panel on Gastric Surgery for Severe Obesity defined the population who would most likely benefit from bariatric surgery. These same criteria continue to be used today to determine which patients should undergo metabolic and weight loss surgery. These recommendations include patients who have a BMI greater than 35 kg/m(2) with significant comorbid conditions such as diabetes, hypertension, or obstructive sleep apnea; and patients who have a BMI greater than 40 kg/m(2) with or without any significant comorbid conditions because they have a significant increased risk for developing these conditions.

摘要

在美国,肥胖症的发病率持续上升。肥胖定义为体质量指数(BMI)大于 30 kg/m(2)。1991 年,美国国立卫生研究院(NIH)肥胖症胃旁路手术共识小组将最有可能从减重手术中获益的人群定义为肥胖症患者。这些相同的标准至今仍被用于确定哪些患者应接受代谢和减重手术。这些建议包括 BMI 大于 35 kg/m(2)且存在显著合并症,如糖尿病、高血压或阻塞性睡眠呼吸暂停;或 BMI 大于 40 kg/m(2),无论是否存在显著合并症,因为这些患者发生这些疾病的风险显著增加。

相似文献

1
The surgical treatment of metabolic disease and morbid obesity.代谢疾病与病态肥胖的外科治疗。
Gastroenterol Clin North Am. 2010 Mar;39(1):125-33. doi: 10.1016/j.gtc.2009.12.010.
2
Short-term outcomes for super-super obese (BMI > or =60 kg/m2) patients undergoing weight loss surgery at a high-volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and open tubular gastric bypass.在一家大型减肥手术中心接受减肥手术的超级肥胖(BMI≥60 kg/m²)患者的短期结局:腹腔镜可调节胃束带术、腹腔镜胃旁路术和开放式管状胃旁路术。
Surg Obes Relat Dis. 2008 May-Jun;4(3):408-15. doi: 10.1016/j.soard.2007.10.013. Epub 2008 Feb 1.
3
The surgical management of severe obesity.重度肥胖的外科治疗
Mt Sinai J Med. 2004 Jan;71(1):63-71.
4
Predictors of prolonged hospital stay following open and laparoscopic gastric bypass for morbid obesity: body mass index, length of surgery, sleep apnea, asthma, and the metabolic syndrome.肥胖症患者接受开放式和腹腔镜胃旁路手术后住院时间延长的预测因素:体重指数、手术时长、睡眠呼吸暂停、哮喘和代谢综合征。
Obes Surg. 2004 Sep;14(8):1042-50. doi: 10.1381/0960892041975460.
5
Bariatric surgery.减肥手术。
J La State Med Soc. 2005 Jan;157 Spec No 1:S65-75.
6
[Surgery of morbid obesity in the adult: clinical efficacy of different surgical procedures].[成人病态肥胖症的外科治疗:不同手术方法的临床疗效]
J Chir (Paris). 2002 Sep;139(4):194-204.
7
Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 5-year results of a prospective randomized trial.腹腔镜可调节胃束带术与Roux-en-Y胃旁路术:一项前瞻性随机试验的5年结果
Surg Obes Relat Dis. 2007 Mar-Apr;3(2):127-32; discussion 132-3. doi: 10.1016/j.soard.2006.12.005. Epub 2007 Feb 27.
8
Choosing an operation for weight control, and the transected banded gastric bypass.选择用于体重控制的手术,以及横断带状胃旁路术。
Obes Surg. 2005 Jan;15(1):114-21. doi: 10.1381/0960892052993404.
9
Bariatric surgery outcomes.减重手术的结果。
Surg Clin North Am. 2011 Dec;91(6):1313-38, x. doi: 10.1016/j.suc.2011.08.014.
10
[Surgical treatment of morbid obesity].[病态肥胖的外科治疗]
Tidsskr Nor Laegeforen. 2007 Jan 4;127(1):38-42.

引用本文的文献

1
Gut microbiome: Linking together obesity, bariatric surgery and associated clinical outcomes under a single focus.肠道微生物群:在单一关注点下将肥胖、减肥手术及相关临床结果联系起来
World J Gastrointest Pathophysiol. 2022 May 22;13(3):59-72. doi: 10.4291/wjgp.v13.i3.59.
2
Changes in Frequency Intake of Foods in Patients Undergoing Sleeve Gastrectomy and Following a Strict Dietary Control.接受袖状胃切除术并遵循严格饮食控制的患者食物摄入频率的变化。
Obes Surg. 2018 Jun;28(6):1659-1664. doi: 10.1007/s11695-017-3072-0.
3
Medication and nutritional supplement use before and after bariatric surgery.
减肥手术前后的药物和营养补充剂使用情况。
Sao Paulo Med J. 2016 Oct 31;134(6):0. doi: 10.1590/1516-3180.2015.0241030516.
4
The Effect of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy Surgery on Dietary Intake, Food Preferences, and Gastrointestinal Symptoms in Post-Surgical Morbidly Obese Lebanese Subjects: A Cross-Sectional Pilot Study.Roux-en-Y胃旁路术和袖状胃切除术对黎巴嫩病态肥胖术后患者饮食摄入、食物偏好及胃肠道症状的影响:一项横断面试点研究
Obes Surg. 2015 Dec;25(12):2393-9. doi: 10.1007/s11695-015-1713-8.
5
Lorcaserin for the treatment of obesity? A closer look at its side effects.洛卡塞林用于治疗肥胖症?深入审视其副作用。
Open Heart. 2014 Oct 18;1(1):e000173. doi: 10.1136/openhrt-2014-000173. eCollection 2014.
6
The use of VivaSight™ single lumen endotracheal tube in morbidly obese patients undergoing laparoscopic sleeve gastrectomy.VivaSight™单腔气管内导管在接受腹腔镜袖状胃切除术的病态肥胖患者中的应用。
BMC Anesthesiol. 2014 May 5;14:31. doi: 10.1186/1471-2253-14-31. eCollection 2014.
7
Gastric bypass and sleeve gastrectomy: the same impact on IL-6 and TNF-α. Prospective clinical trial.胃旁路术和袖状胃切除术:对 IL-6 和 TNF-α 的影响相同。前瞻性临床试验。
Obes Surg. 2013 Aug;23(8):1252-61. doi: 10.1007/s11695-013-0894-2.
8
Vitamin, mineral, and drug absorption following bariatric surgery.减重手术后的维生素、矿物质和药物吸收。
Curr Drug Metab. 2012 Nov;13(9):1345-55. doi: 10.2174/138920012803341339.
9
Additive feeding inhibitory and aversive effects of naltrexone and exendin-4 combinations.纳曲酮和 exendin-4 组合的添加喂养抑制和厌恶效应。
Int J Obes (Lond). 2013 Feb;37(2):272-8. doi: 10.1038/ijo.2012.16. Epub 2012 Feb 7.
10
Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes.胃旁路手术对伴有和不伴有 2 型糖尿病的病态肥胖患者组织特异性胰岛素敏感性和胰岛β细胞功能的早期和长期影响。
Diabetologia. 2011 Aug;54(8):2093-102. doi: 10.1007/s00125-011-2193-6. Epub 2011 May 26.